Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 4 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER.
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER vs PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 4/0 is a sterile, bicarbonate-based hemofiltration solution used in continuous renal replacement therapy (CRRT). It replaces electrolytes and buffers in the blood, correcting metabolic acidosis and removing waste products via convection and diffusion. The solution contains bicarbonate as a buffer to maintain acid-base balance.
Prismasol BGK 2/3.5 is a sterile, non-pyrogenic hemofiltration solution used in continuous renal replacement therapy (CRRT). It does not have a pharmacological mechanism of action; rather, it provides electrolyte composition (sodium, potassium, calcium, magnesium, chloride, lactate) and glucose to replace fluid and electrolyte losses during hemofiltration or hemodialysis, maintaining acid-base balance and electrolyte homeostasis. The lactate in the solution serves as a bicarbonate precursor, metabolized to bicarbonate by the liver, helping to correct metabolic acidosis.
Continuous renal replacement therapy (CRRT): 1.5-2.0 L/h effluent rate, typically administered as continuous venovenous hemofiltration (CVVH) or hemodiafiltration (CVVHDF). Route: intravenous via CRRT circuit. Frequency: continuous infusion.
PRISMASOL BGK 2/3.5 is a hemofiltration solution for continuous renal replacement therapy (CRRT). Administered intravenously via CRRT circuit. Typical adult dose: 1000-2000 mL/hour infusion rate adjusted to achieve effluent rate of 20-35 mL/kg/hour.
None Documented
None Documented
Not applicable as a drug; the half-life of infused bicarbonate/lactate in patients is approximately 5–10 minutes for lactate conversion and bicarbonate distribution, but this is not relevant to the solution itself.
Not applicable as a single terminal half-life; components are endogenous substances with rapid turnover (e.g., lactate t1/2 ~10-20 min, electrolytes adjust within minutes to hours).
Prismasol B22GK 4/0 is a dialysis solution containing electrolytes and buffer (bicarbonate/lactate). It is not systemically absorbed; during continuous renal replacement therapy (CRRT), solutes and fluid are removed via hemofiltration/dialysis. The solution components are eliminated by the dialysis membrane and not subject to systemic excretion.
The components are primarily excreted renally: sodium, potassium, and glucose are eliminated via urine; bicarbonate is consumed or excreted as CO2; lactate is metabolized to bicarbonate. ~100% renal for electrolytes.
Category C
Category C
Dialysis Solution
Dialysis Solution